Working… Menu
Trial record 4 of 4 for:    KZR-616

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis (PRESIDIO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04033926
Recruitment Status : Active, not recruiting
First Posted : July 26, 2019
Last Update Posted : August 24, 2021
Information provided by (Responsible Party):
Kezar Life Sciences, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : April 2022